Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Complete Genomics Deal Clears Last Regulatory Hurdle

NEW YORK (GenomeWeb News) – The State Administration of Foreign Exchange of the People's Republic of China has approved BGI's proposed $118 million acquisition of Complete Genomics, the companies said today, setting the stage for the completion of the acquisition.

The deal has now received all necessary regulatory approvals, BGI and Complete said. The Ministry of Commerce of the People's Republic of China approved the deal a few weeks ago, and US regulators cleared the deal in January.

The cash tender offer for the deal has been extended several times and is now set to expire at 11:59 PM EDT, March 14.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.